PrimeC is NeuroSense's lead drug candidate for ALS, a novel extended-release oral formulation combining ciprofloxacin and celecoxib. The drug has demonstrated promising results in clinical trials, ...

We recently published a list of the 7 Most Undervalued Biotech Stocks To Invest In. In this article, we are going to take a ...

Swiss drugmaker Roche has abandoned global diverse workforce targets and compatriot Novartis is ending its use of diverse ...

Pfizer Inc. is looking to sell its remaining 7.3% stake in Haleon Plc, culminating a multi-year separation from the maker of ...

Duska noted that the PD-L1 inhibitor pembrolizumab has shown efficacy in the treatment of recurrent or metastatic cervical ...

The finance sector is strongly represented in this year's attendees. HSBC Group Chief Executive Georges Elhedery is on the ...

Fan Zhang, PhD, of the University of Colorado Department of Medicine sees artificial intelligence as a pathway to combating an intractable enemy: rheumatoid arthritis.

UK drugmaker GlaxoSmithKline Limited (GSK) has rebranded to Haleon Kenya Limited, effective March 14, 2025.The rebrand comes after GSK transferred its consumer health business to Haleon to focus on ...

Getting a headache and feeling sick are common side-effects for many medicines. Indulging in risky sexual behavior or ...

Curevo, a Seattle-based biotech startup developing a vaccine against shingles, raised $110 million in a Series B ...

It is not clear what would become of the federal government’s health care enforcement efforts without the False Claims Act’s qui tam program.